Top Company News of the Day: Glencore, Novartis, Illumina, Eisner

Glencore Approaches Teck Over Its Coal Business

The commodities giant is willing to buy Teck’s unit as an alternative to a full merger.

Novartis to Buy U.S.-Based Chinook

Novartis has agreed to acquire Chinook Therapeutics for up to $3.5 billion, in a deal that will expand its portfolio of kidney disease treatments.

Illumina CEO Francis deSouza Resigns

Activist investor Carl Icahn has signaled he wants former Chief Executive Jay Flatley to return to the gene-sequencing test maker.

Eisner’s Bazooka Gum Hits Auction Block

The iconic candy company has attracted interest from buyout firms and could fetch around $700 million in a sale.

Netflix Subscriptions Jump as U.S. Password-Sharing Crackdown Begins

Shortly after the change, the streaming service had its highest rate of sign-ups since Antenna began tracking data in 2019.

FDA Advisory Committee Votes in Favor of Biogen Alzheimer’s Drug

The vote came two and a half years after the same panel dealt a decisive blow to Aduhelm, another drug from Biogen and Eisai.

CEO Takes Shell’s Pitch Direct to Wall Street

Wael Sawan signals openness to more oil production in an effort to woo investors.

Auto-Parts Maker Resisting Recall Request Had Workplace-Safety Woes

ARC Automotive, the Chinese-owned maker of 67 million air-bag inflators that regulators want recalled, has faced safety violations and litigation over allegedly flawed parts.

Tech, an Early Booster of Remote Work, Wants People Back in the Office

The reversal is creating tension for workers who adjusted to the flexibility gained during the pandemic and arranged their lives accordingly.

U.S. Tech Giants Are Slowly Cutting Off Hong Kong Internet Users

Google and OpenAI haven’t rolled out AI chatbots to the city, putting it alongside mainland China and North Korea.

Source: Dow Jones Newswires


Posted

in

by

Tags: